Capecitabine
Product Images NDC 59923-721

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Capecitabine (NDC 59923-721). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Areva Pharmaceuticals, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Bottle-label (150mg Label)

Bottle-label (150mg Label)
This is a partial label of Capecitabine St tablets. The tablets are 150mg each. The label includes some standard information such as the drug name, strength, and formulation. However, due to errors and misplaced characters, some of the information is not clear.*
FDA Label Image

Bottle-label (500mg Label)

Bottle-label (500mg Label)
This is a description of a medicine in tablet form, with a quantity of 120 tablets. It includes information on dosages and the type of tablet, which is the CapeCItablne tablet, USP with a strength of 500mg. The text also mentions that this medicine is a cytotoxic agent. The NDC code is 50923-722-12.*
FDA Label Image

Figure-1 (Figure 1)

Figure-1 (Figure 1)
FDA Label Image

Figure-2 (Figure 2)

Figure-2 (Figure 2)
FDA Label Image

Figure-3 (Figure 3)

Figure-3 (Figure 3)
FDA Label Image

Figure-4 (Figure 4)

Figure-4 (Figure 4)
FDA Label Image

Figure-5 (Figure 5)

Figure-5 (Figure 5)
FDA Label Image

Metabolic-pathway (Metabolic Pathway)

Metabolic-pathway (Metabolic Pathway)
FDA Label Image

Structure (Structure)

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.